ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 65 filers reported holding ATRECA INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,727 | -79.6% | 56,424 | -23.4% | 0.00% | – |
Q2 2023 | $72,228 | +47733.1% | 73,702 | -44.2% | 0.00% | – |
Q1 2023 | $151 | -32.3% | 132,087 | -52.5% | 0.00% | – |
Q4 2022 | $223 | -99.9% | 278,322 | +28.4% | 0.00% | – |
Q3 2022 | $340,000 | -51.9% | 216,772 | -45.1% | 0.00% | – |
Q2 2022 | $707,000 | +1583.3% | 395,071 | +2858.4% | 0.00% | – |
Q1 2022 | $42,000 | -97.0% | 13,354 | -97.1% | 0.00% | -100.0% |
Q4 2021 | $1,400,000 | -47.9% | 461,902 | +7.0% | 0.00% | -50.0% |
Q3 2021 | $2,688,000 | -30.6% | 431,517 | -5.1% | 0.00% | 0.0% |
Q2 2021 | $3,873,000 | -1.4% | 454,563 | +77.4% | 0.00% | -33.3% |
Q1 2021 | $3,927,000 | -48.5% | 256,164 | -45.7% | 0.00% | -50.0% |
Q4 2020 | $7,624,000 | -4.5% | 472,089 | -17.4% | 0.01% | -40.0% |
Q3 2020 | $7,986,000 | +301.5% | 571,633 | +511.7% | 0.01% | +233.3% |
Q2 2020 | $1,989,000 | -9.1% | 93,457 | -29.3% | 0.00% | -40.0% |
Q1 2020 | $2,188,000 | +210.4% | 132,203 | +129.3% | 0.01% | +400.0% |
Q3 2019 | $705,000 | +43.6% | 57,649 | +121.2% | 0.00% | 0.0% |
Q2 2019 | $491,000 | – | 26,064 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
CM Management, LLC | 249,282 | $391,000 | 0.44% |
Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |